Our studies suggest that FKN isoforms can produce diverse outcomes in the context of neurodegenerative diseases that is likely linked to their ability to elicit different changes in microglial and neuronal phenotype [21, 34, 51]. The gene discussed is CX3CL1; the disease is neurodegenerative disease.